Peripheral ulcerative keratitis 'corneal melt' and rheumatoid arthritis: A case series

Rheumatology

Volumn 38, Issue 12, 1999, Pages 1245-1248

  Squirrell, D M ^a   Winfield, J ^a   Amos, R S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin; Immunosuppression; Peripheral ulcerative keratitis; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORNEA TRANSPLANTATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KERATITIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC VASCULITIS; VISUAL ACUITY;

EID: 0032786312     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.12.1245     Document Type: Article

References (17)

1. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis; effects of systemic immunosuppression. Ophthalmology 1984;91:1253-63.
2. Jifi-Bahool H, Saadeh C, O'Connor J. Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy. Semin Arthritis Rheum 1995;25:67-73.
3. Messmer EM, Foster S. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999;43:379-96.
4. Bron AJ, Tripath R, Tripath B, eds. The cornea. WoIff's anatomy of the eye and orbit. London: Chapman and Hall, 1997:247-51.
5. Riley GP, Harral RL, Watson PG, Cawston TE, Hazleman BL. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995;9:703-18.
6. Kervick GN, Pflugfelder SC, Haimovici R, Brown H, Tozman E, Yee R. Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporin therapy. Ophthalmology 1992;99:80-8.
7. John SL, Morgan K, Tullo AB, Holt PJL. Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis. Eye 1992;6:630-6.
8. Diaz-Valle D, Benitez del Castillo JM, Sayagues O, Banares A, Garcia-Sanchez J. Immunologic and clinical evaluation of postsurgical necrotizing sclerocorneal ulceration. Cornea 1998;17:371-5.
9. Michels ML, Cobo M, Caldwell DS, Rice JR, Haynes BF. Rheumatoid arthritis and sterile corneal ulceration; analysis of tissue immune effector cells and ocular epithelial antigens using monoclonal antibodies. Arthritis Rheum 1984;27:606-14.
10. Messmer E, Foster S. Destructive corneal and scieral disease associated with rheumatoid arthritis; medical and surgical management. Cornea 1995;14:408-17.
11. Kenyon KR. Decision making in the therapy of external eye disease: non infected corneal ulcers. Ophthalmology 1992;89:44-51.
12. McCarthy JM, Dubord PJ, Chalmers A, Kassen BO, Rangno KK. Cyclosporin A for the treatment of necrotising scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol 1992;19:1358-61.
13. Bernauer W, Ficker LA, Watson PG, Dart JKG. The management of corneal perforations associated with rheumatoid arthritis. Ophthalmology 1995;102:1325-37.
14. Verhoeven AC, Boers M, Tugwell P. Combination therapy in rheumatoid arthritis; updated systematic review. Br J Rheumatol 1998;37:612-9.
15. Hill JC. Systemic cyclosporin in high risk keratoplasty: long-term results. Eye 1995;9:422-8.
16. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993;12:413-9.
17. Liegner JT, Yee RW, Wild JH. Topical cyclosporin therapy for ulcerative keratitis associated with rheumatoid arthritis. Am J Ophthalmol 1990;109:610-1.